title: Re: Tumefactive multiple sclerosis lesions under fingolimod treatment.
authors.forename: Michael O
authors.initials: MO
authors.lastname: Kinney
authors.forename: Gavin
authors.initials: G
authors.lastname: McDonnell
mesh_terms: D001921:Brain / Q000473:pathology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000473:pathology*; D009413:Nerve Fibers, Myelinated / Q000473:pathology*; D011409:Propylene Glycols / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives*
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D013110:Sphingosine